Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
3Billion is currently managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions involve 2 distinct examiners but are concentrated within 1 distinct art unit, suggesting a consistent technical environment for the company patent portfolio. The busiest examiner, WISE, OLIVIA M., is responsible for 1 busiest examiner pending office action.
While the portfolio utilizes 2 distinct examiners, the focus on 1 distinct art unit means that prosecution is likely governed by a unified set of internal USPTO policies. This concentration allows the legal team to develop a specialized approach for the Biotechnology & Pharmaceuticals sector matters. With the busiest examiner handling 1 busiest examiner pending action, the prosecution responsibility is shared between the 2 distinct examiners.
Practitioners should recognize that having 2 pending office actions in 1 distinct art unit provides an opportunity to observe examiner trends within a single group. Although WISE, OLIVIA M. is the busiest examiner, the interaction with both examiners will shape the overall portfolio results. Successfully resolving the 2 pending office actions is a priority, but the strategy must remain effective for the entire active portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WISE, OLIVIA M. | 1 | 33.9% | +29.9% |
| BICKHAM, DAWN MARIE | 1 | 46.2% | +64.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17644339 | SYSTEM FOR PATHOGENICITY PREDICTION OF GENOMIC VARIANT USING KNOWLEDGE TRANSFER | BICKHAM, DAWN MARIE | 19d overdue |
| 17817221 | SYSTEM AND METHOD FOR PREDICTING LOSS OF FUNCTION CAUSED BY GENETIC VARIANT | WISE, OLIVIA M. | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17644339 | SYSTEM FOR PATHOGENICITY PREDICTION OF GENOMIC VARIANT USING KNOWLEDGE TRANSFER | BICKHAM, DAWN MARIE | 19d overdue |
| 17817221 | SYSTEM AND METHOD FOR PREDICTING LOSS OF FUNCTION CAUSED BY GENETIC VARIANT | WISE, OLIVIA M. | — |
| Art Unit | Apps |
|---|---|
| 1685 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17817221 | SYSTEM AND METHOD FOR PREDICTING LOSS OF FUNCTION CAUSED BY GENETIC VARIANT | WISE, OLIVIA M. | 1685 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 03, 2022 |
| 17644339 | SYSTEM FOR PATHOGENICITY PREDICTION OF GENOMIC VARIANT USING KNOWLEDGE TRANSFER | BICKHAM, DAWN MARIE | 1685 | §101§103§112 | Final Rejection | 19d overdue | Pending | Dec 15, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial